Peptide record

TPDB14620

ACE inhibitors Antibacterial Antifungal Antihypertensive Antiviral Bitter Hemolysis Toxicity Umami standard
2 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB14620
ACE inhibitors Antibacterial Antifungal Antihypertensive Antiviral Bitter Hemolysis Toxicity Umami
Anti-infective peptides Cardiometabolic peptides Toxicity and safety peptides Food sensory peptides
Peptipedia dbAMP DRAMP CAFPdb AHTPDB dbAMP 3.0 Tastepeptides-Meta PD_Hemolysis
standard
No
A 2-aa standard-residue multi-activity (ACE inhibitors, Antibacterial, Antifungal, and other sources) peptide sequence curated from Peptipedia, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
LE
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C11H20N2O5
ARNDCQGHIKMFPSTWYV
EL
260.29
3.29
0
1
1
-1
0.94
0.150
195.00
Mammalian: 5.5 hour Yeast: 3 min E.coli: 2 min
0
0.00
0
Residue Composition
number
0
A
0
R
0
N
0
D
0
C
1
E
0
Q
0
G
0
H
0
I
1
L
0
K
0
M
0
F
0
P
0
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
2 reviewed residue count
C11H20N2O5 sequence-only estimate (linear, free termini)
260.29 sequence-only estimate (linear, free termini)
3.29 sequence-only estimate (linear, free termini)
-1 sequence-only estimate (linear, free termini)
0.94 sequence-only estimate (linear, free termini)
0.150 sequence-only estimate (linear, free termini)
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
>>100 µM
Hemolytic Cytotoxic
50% Hemolysis | >>100 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Small lipopeptides possess anti-biofilm capability comparable to daptomycin and vancomycin. | RSC Adv | 2015
Evidence 2 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis